263 studies found for:    "Tetanus"
Show Display Options
Rank Status Study
21 Active, not recruiting Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents
Conditions: Diphtheria;   Tetanus;   Pertussis
Interventions: Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP vaccine, BK1301);   Biological: Adsorbed Diphtheria-Tetanus Combined Toxoid (DT toxoid)
22 Recruiting Regulatory Post-Marketing Surveillance Study for TETRAXIM™
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Intervention: Biological: TETRAXIM™: Combined adsorbed diphtheria, tetanus, acellular pertussis and enhanced inactivated polio
23 Completed
Has Results
Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX®
Conditions: Pertussis;   Tetanus;   Diphtheria
Interventions: Biological: ADACEL®:Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed;   Biological: BOOSTRIX®: Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed
24 Completed
Has Results
Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine
Conditions: Tetanus;   Diphtheria;   Pertussis
Intervention: Biological: Tetanus-diphtheria-acellular pertussis (Tdap) vaccine
25 Completed Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Haemophilus Influenzae Type B
Interventions: Biological: Shan 5;   Biological: Easy Five
26 Completed Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine
Conditions: Diphtheria;   Tetanus;   Whooping Cough;   Polio;   Haemophilus Influenzae Type b
Interventions: Biological: DAPTACEL® (Diphtheria and Tetanus Toxoids and Acellular Pertussis vaccine);   Biological: Pentacel: DTaP-IPV/Hib
27 Completed
Has Results
Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine
Conditions: Meningitis;   Meningococcemia;   Pertussis;   Tetanus;   Diphtheria
Interventions: Biological: T dap + Meningococcal Polysaccharide Diphtheria Toxoid Conj.;   Biological: Tdap + Meningococcal Polysaccharide Diphtheria Toxoid Conj.;   Biological: Meningococcal Polysaccharide Diphtheria Toxoid Conj. + T dap
28 Completed
Has Results
Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™
Conditions: Diphtheria;   Tetanus;   Pertussis;   Polio;   Haemophilus Infection
Intervention: Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis (DAPTACEL®)
29 Completed
Has Results
Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®
Conditions: Meningococcal Meningitis;   Tetanus;   Diphtheria;   Pertussis;   Poliomyelitis
Intervention: Biological: Polysaccharide Diphtheria Toxoid Conjugate Vaccine
30 Completed Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis;   Haemophilus Influenzae Type b
Interventions: Biological: PEDIACEL®  and Prevenar®;   Biological: Infanrix®-IPV+Hib and Prevenar®
31 Completed
Has Results
Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine
Conditions: Pertussis;   Diphtheria;   Tetanus;   Poliomyelitis
Intervention: Biological: COVAXIS™: Tetanus, diphtheria, acellular 5-component pertussis, or + inactivated poliovirus vaccine (REPEVAX®)
32 Recruiting Post-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in Korea
Conditions: Acellular Pertussis;   Diphtheria;   Tetanus;   Poliomyelitis
Intervention: Other: Infanrix-IPV data collection
33 Completed Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants
Conditions: Pertussis;   Diphtheria;   Tetanus;   Poliomyelitis;   Haemophilus Influenzae Type b
Interventions: Biological: DT5aP-IPV-Hib 5-component Pertussis vaccine;   Biological: Infanrix® -IPV+Hib
34 Completed Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy Adults
Conditions: Diphtheria;   Pertussis;   Tetanus
Interventions: Biological: GSK Biologicals' combined diphtheria, tetanus, acellular pertussis vaccine;   Biological: GSK Biologicals' acellular pertussis vaccine;   Biological: Commonwealth Serum Laboratories' combined diphtheria and tetanus vaccine
35 Completed
Has Results
Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED)
Conditions: Neoplasms, Glandular and Epithelial;   Diphtheria;   Tetanus;   Whooping Cough;   Poliomyelitis
Interventions: Biological: Comparator: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant (qHPV) Vaccine from Current Manufacturing Facility (CMF);   Biological: Comparator: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant (qHPV) Vaccine from Future Manufacturing Facility (FMF);   Biological: Comparator: REPEVAX™ (Concomitant);   Biological: Comparator: REPEVAX™ (Non-Concomitant)
36 Completed
Has Results
Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)
Conditions: Neoplasms, Glandular and Epithelial;   Diphtheria;   Tetanus;   Whooping Cough;   Meningitis
Interventions: Biological: Comparator: Quadrivalent Human Papillomavirus (HPV) vaccine;   Biological: Comparator: Menactra™ (Concomitant);   Biological: Comparator: Adacel™ (Concomitant);   Biological: Comparator: Menactra™ (Non-concomitant);   Biological: Comparator: Adacel™
37 Completed Comparison of GSK Biologicals' Reduced Antigen Diphtheria and Tetanus Toxoids and Acellular Pertussis- Inactivated Poliovirus Vaccine, to BoostrixTM and Inactivated Poliovirus Vaccine Administered Separately and With Revaxis®
Conditions: Poliomyelitis;   Diphtheria;   Pertussis;   Tetanus
Interventions: Biological: GSK Biologicals' reduced antigen diphtheria and tetanus toxoids and acellular pertussis- inactivated poliovirus vaccine;   Biological: Boostrix™;   Biological: GSK Biologicals' IPV vaccine;   Biological: Revaxis®
38 Completed Post-marketing Safety Study of GSK Biologicals' Boostrix® Vaccine
Conditions: Diphtheria;   Tetanus;   Acellular Pertussis
Interventions: Biological: Boostrix®;   Biological: Td (Tetanus diphtheria) vaccine
39 Recruiting Post-marketing Surveillance to Assess the Safety of Boostrix Vaccine Given According to Prescribing Information in Korea
Conditions: Tetanus;   Acellular Pertussis;   Diphtheria
Interventions: Biological: Boostrix;   Other: Safety data collection
40 Completed
Has Results
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents
Conditions: Meningococcal Meningitis;   Human Papillomavirus Infection;   Pertussis;   Tetanus
Interventions: Biological: Novartis Meningococcal ACWY Conjugate Vaccine;   Biological: Tdap Vaccine

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years